Want to contact a Washington, DC Remicade lawyer? ...Get a free case evaluation from one of our Washington, DC Remicade lawyers now.
Home : Unsafe Drugs : Remicade : MSN Newsfeeds
Remicade - MSN Newsfeeds
- TradingMarkets.com - However, the claims against Johnson & Johnson that it inflated the price of Remicade drug for Crohn's disease were dismissed and the judge ruled that that while Johnson & Johnson's "conduct was at times troubling, it did not rise to the level of ...
- HULIQ.com - Data presented at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology showed that patients with ankylosing spondylitis (AS) who received REMICADE® (infliximab) over two years experienced significant improvement in ...
- Medical News Today - Data presented at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology showed that patients with ankylosing spondylitis (AS) who received REMICADE® (infliximab) over two years experienced significant improvement in ...
- Nashua Telegraph - Currently, Beuchner receives infusion treatment, called Remicade, every three months. She began receiving the treatment two years ago. The four-hour sessions have halted her Crohn’s flare-ups, though she must continue to follow a regimented diet ...
- Times Online - Experience has shown that Enbrel (etanercept) and Remicade (infliximab) can usually be recommended, used with methotrexate, in treatment of rheumatoid arthritis that is not responding to other drugs. Enbrel (etanercept) is used in juvenile ...
- Daily Telegraph - The National Institute for Health and Clinical Excellence (Nice) has partially upheld an appeal over the use of the rheumatoid arthritis medicines, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade). Last November, it said patients ...
- PR Newswire - Although the emergence of novel biologic agents combined with sales of currently marketed biologics such as Amgen/Wyeth/Takeda's Enbrel and Centocor/Schering-Plough/Tanabe's Remicade will drive near-term market growth, market expansion will slow ...
- Channel 4 News - The National Institute for Health and Clinical Excellence (Nice) has partially upheld an appeal over the use of the rheumatoid arthritis medicines, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade). Last November, it said patients ...
- Times Online - ... celebrating yesterday after the National Institute for Health and Clinical Excellence agreed to review its decision preventing sufferers from trying more than one of three drugs – adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade ...
- Motley Fool - Last week pharma giant Schering-Plough (NYSE: SGP ) announced that the European Union had approved its blockbuster drug Remicade to treat a new indication. SGP also said that it had begun initial marketing of cholesterol-lowering drug Zetia in Japan ...
- Adweek - When Johnson & Johnson unit Centocor deliberated marketing immune disorder drug Remicade, it decided to forgo traditional TV and print. Instead, it created a nearly hour-long film, Innerstate , focusing on the lives of three patients facing chronic ...
- Australian Broadcasting Corp. - Sarah Hird, 22, will eventually have her bowel removed if she cannot keep up with the $18,000 a year she needs for the drug Infliximab to keep her illness under control. "There's got to be something the Government can do for us," she said. "It has to ...
- WHNT-TV - This was infliximab (Remicade®), which is indicated for moderately to severely active Crohn's in patients who have not responded adequately to conventional therapy . It is also approved for reducing the number of draining enterocutaneous fistulas. In ...
- Detroit News - Since the turn of the 21st century, a new era has dawned in treatment. Drugs such as Remicade and Enbrel have freed many ankylosing spondylitis patients from the locked-in positions that the disease had forced on them. Physical therapy is a must. ...
- Wall Street Journal - Competitors to Humira for certain diseases include Johnson & Johnson's Remicade and the drug Enbrel, which is co-marketed by Amgen Inc. and Wyeth . Also, Belgian pharmaceutical company UCB SA is targeting its drug Cimzia at multiple diseases. Remicade is ...
- Medical News Today - Findings presented at Digestive Disease Week 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects with moderately to severely active ulcerative colitis (UC) who had responded to REMICADE ...
- Forbes - Injectable protein therapeutics currently on the market, such as Enbrel, Remicade, Humira and Kineret, bind to and/or modulate the activity of the inflammatory cytokines TNF or IL-1. There remains a significant unmet medical need for improved ...
- Ledger - The leading current treatment for Crohn's is Remicade, manufactured by Johnson & Johnson. Analysts say, if given FDA approval, Tysabri probably would be prescribed only to those Crohn's sufferers who were not responding to treatment from longer ...
- KFOR - Federal prosecutors say Doctor Gregory Glase Pinegar admitted sending false bills to Medicare from January 2000 through May 2005 for the prescription drugs Procrit and Remicade. Procrit is used to treat anemia and Remicade is used to treat Crohn's ...
- MSN MoneyCentral - HUMIRA is also indicated for reducing the signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab, the only other approved biologic for treatment of Crohn's disease ...
Want to contact a Washington, DC Remicade lawyer? ...Get a free case evaluation from one of our Washington, DC Remicade lawyers now.
Pages: 1 2 3 4 5 6 ... Next
